[go: up one dir, main page]

MX9206710A - PIRIDINOL DERIVATIVES - Google Patents

PIRIDINOL DERIVATIVES

Info

Publication number
MX9206710A
MX9206710A MX9206710A MX9206710A MX9206710A MX 9206710 A MX9206710 A MX 9206710A MX 9206710 A MX9206710 A MX 9206710A MX 9206710 A MX9206710 A MX 9206710A MX 9206710 A MX9206710 A MX 9206710A
Authority
MX
Mexico
Prior art keywords
piridinol
derivatives
piridinol derivatives
Prior art date
Application number
MX9206710A
Other languages
Spanish (es)
Inventor
Kenneth John Murray
Roderick Alan Porter
Hunter Douglas Prain
Brian Herbert Warrington
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9206710A publication Critical patent/MX9206710A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX9206710A 1991-11-20 1992-11-19 PIRIDINOL DERIVATIVES MX9206710A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919124578A GB9124578D0 (en) 1991-11-20 1991-11-20 Chemical compounds

Publications (1)

Publication Number Publication Date
MX9206710A true MX9206710A (en) 1993-05-01

Family

ID=10704881

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9206710A MX9206710A (en) 1991-11-20 1992-11-19 PIRIDINOL DERIVATIVES

Country Status (11)

Country Link
EP (1) EP0613476A1 (en)
JP (1) JPH07501070A (en)
AU (1) AU2930392A (en)
CA (1) CA2124002A1 (en)
GB (1) GB9124578D0 (en)
MX (1) MX9206710A (en)
NZ (1) NZ245167A (en)
PT (1) PT101072A (en)
TW (1) TW221990B (en)
WO (1) WO1993010114A1 (en)
ZA (1) ZA928893B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036873A1 (en) 2001-09-07 2004-10-13 Euro Celtique Sa PIRIDINAS ARIL REPLACED A, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT
AR037233A1 (en) 2001-09-07 2004-11-03 Euro Celtique Sa PIRIDINAS ARIL REPLACED, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CA2577846A1 (en) 2004-08-23 2006-03-02 Wyeth Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
JP2008510815A (en) 2004-08-23 2008-04-10 ワイス Oxazolo-naphthylic acid as plasminogen activator inhibitor type 1 (PAI-1), a modulator useful in the treatment of thrombosis and cardiovascular disease
AU2005277137A1 (en) 2004-08-23 2006-03-02 Wyeth Pyrrolo-naphthyl acids as PAI-1 inhibitors
US9271963B2 (en) * 2005-03-03 2016-03-01 Universitat Des Saarlandes Selective inhibitors of human corticosteroid synthases
WO2023240253A2 (en) * 2022-06-10 2023-12-14 Forward Therapeutics, Inc. Modulators of tnf-alpha activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8923131D0 (en) * 1989-10-13 1989-11-29 Smith Kline French Lab Chemical compounds
JPH05509296A (en) * 1990-05-21 1993-12-22 スミス・クライン・アンド・フレンチ・ラボラトリース・リミテッド Phenol and pyridinol derivatives for pharmaceutical use
PT99081A (en) * 1990-09-28 1992-08-31 Smith Kline French Lab PREPARATION PROCESS OF PHENYLPYRIDINOL DERIVATIVES, ITS INTERMEDIARIES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
WO1993010114A1 (en) 1993-05-27
NZ245167A (en) 1995-08-28
TW221990B (en) 1994-04-01
AU2930392A (en) 1993-06-15
PT101072A (en) 1994-02-28
ZA928893B (en) 1994-05-18
JPH07501070A (en) 1995-02-02
CA2124002A1 (en) 1993-05-27
GB9124578D0 (en) 1992-01-08
EP0613476A1 (en) 1994-09-07

Similar Documents

Publication Publication Date Title
DE69208877D1 (en) CHINUCLIDINE DERIVATIVES
FI924160A7 (en) BENZANE DERIVATIVES
FI935726A7 (en) Azanorbornane derivatives
FI924159L (en) BENZANE DERIVATIVES
NO922182L (en) CRYSTALLINIC OXATATOLAN DERIVATIVES
FI930262L (en) KINUCLIDEN DERIVATIVES
DE69119329D1 (en) Actinonine derivatives
DE69125099D1 (en) INDOLDER DERIVATIVES
ATA75293A (en) INDOLDER DERIVATIVES
FI925523A0 (en) HYDROXI-OCH ALCOXYPYRIDE DERIVATIVES
FI913045A7 (en) Heterocyclen derivatives
FI921262L (en) 4-ARYLTHIAZOLE OR 4-ARYLIMIDAZOLE DERIVATIVES
FI930878L (en) A-SUBSTITUERADE TRYPTOPHAN-DIPEPTOIDDER DERIVATIVES
FI925763L (en) FUNGICIDA 2-IMIDAZOLIN-5-ON- OCH 2-IMIDAZOLIN-5-THION DERIVATIVES
FI923726L (en) SULFATERADE GLYCOSAMINOGLYCANOID DERIVATIVES
FI922347A7 (en) Azoxindole derivatives
ATE144765T1 (en) HIV-INHIBITING BENZENACETAMIDE DERIVATIVES
ATE171449T1 (en) OXADOL DERIVATIVES
FI930109L (en) 4-ALKYL-IMIDAZOLE DERIVATIVES
FI935243L (en) PYRIDONECARBOXYL DERIVATIVES
TR26336A (en) SUBSTITUTED PIRAZOLINE DERIVATIVES
DK0472733T3 (en) Phenanthrend derivatives
FI912598A7 (en) Dioxo-tetrahydroquinoline derivatives
FI912759A7 (en) Pyridinylpiperazine derivatives
FI920394A7 (en) 3-quinuclidine derivatives